Institutional Effectiveness, Assessment, Research and Planning

The Division of Institutional Effectiveness, Assessment, Research and Planning is responsible for gathering, maintaining, assessing and analyzing the institution’s data for internal decision-making purposes and external reporting requirements. The division plays a vital leadership role in developing the institution’s long-range goals, to ensure they are mission-driven, based on reliable data and consistent with accreditation criteria. The division also provides oversight for accreditation review processes. The division is the College’s internal clearinghouse whose primary responsibility is to collect, store, and disseminate institutional data. The division exists to enhance the student, faculty, and staff experience by championing data and mission-driven decision-making, to continually improve the quality of its programs and services.

To request a change to the any institutional core publications, please click here to complete the form.

To request access to any previous version of the publications above, please send an email to the Office of Institutional Effectiveness to

Institutional Annual Assessment Report
| 2014 | 2015 | 2016 | 2017

Annual Assessment of Publications Procedures Report
| 2014 | 2015 | 2016 | 2017

Assessment Week Fall 2014
Assessment Week Spring 2015
Assessment Week Fall 2015
Assessment Week Spring 2016
Assessment Week Fall 2016
Assessment Week Spring 2017
Assessment Week Fall 2017
Assessment Week Spring 2018
The primary purpose of the IRB is to protect the rights and welfare of human subjects involved in research activities being conducted under its authority. In so doing, the IRB shall ensure adherence to the criteria for IRB approval as listed in 45 CFR 46.111 and 21 CFR 56.111 i.e., that:

  • The risks to human research subjects are minimized by using procedures that are consistent with sound research design and that do not unnecessarily expose the research participants to risk, and whenever appropriate, by using procedures already being performed on subjects for diagnosis or treatment purposes.
  • The risks to human research subjects are reasonable in relation to the anticipated benefits (if any) to the individual, and the importance of the knowledge that may be expected to result.
    • For the purpose of IRB consideration, “benefit” is defined as a valued or desired outcome; an advantage.
    • For the purpose of IRB consideration, “risk” is defined as the probability of harm or injury (physical, psychological, social, or economic) occurring as a result of participation in a research study.
    • In evaluating risk, the IRB is to consider the conditions that make the situation dangerous, per se (i.e., as opposed to those chances that specific individuals are willing to undertake for some desired goals). In evaluating risks and benefits, the IRB considers only those risks and benefits that may result from the research (i.e., as distinguished from risks and benefits of treatments or procedures that the patient would undergo if not participating in the research).
    • In evaluating risks and benefits, the IRB does not consider possible long-range effects of applying knowledge gained in the research (e.g., the possible effects of research on public policy).
  • The selection of human subjects for research participation is equitable.
  • Human research subjects are adequately informed of the risks and benefits of research participation and the procedures that will be involved in the research; and that informed consent is obtained from each prospective human research subject, or his/her legally authorized representative, in accordance with, and to the extent required by federal regulations and IRB policies.
  • Informed consent of human research subjects is obtained in advance of research participation and appropriately documented in accordance with, and to the extent required by federal regulations and IRB policies.
  • The research plan, when appropriate, makes adequate provisions for monitoring the data collected to ensure the safety of human research subjects.
  • There are adequate provisions to protect the privacy of human research subjects and to maintain the confidentiality of research data.
  • Appropriate additional safeguards have been included in the study to protect the rights and welfare of human research subjects who are likely to be vulnerable to coercion or undue influence (e.g., children, prisoners, pregnant women, decisionally impaired persons, or economically or educationally disadvantaged persons).

As a secondary purpose, the IRB must seek to ensure that the College, affiliate institutions, and the investigators that it serves are compliant with the ethical standards and regulations governing human subject research. The IRB and IRB Committee also serve to assist investigators in the design of ethical and regulatory compliant human subject research studies.

Click here for the IRB Form. Please submit all forms to the


For all institutional data request, please submit the form below. Please note, please allow up to 72 hours for a response to your request.

15 + 14 =